ArticleCell death & disease2019

SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity.

Fan Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.